Launch of Ground-Breaking "Toward Good Simulation Practice" Book to Set New Standards in Biomedical Simulation
CM&S is also a very promising technology into the broader narrative of advancing regulatory science and healthcare innovation.
- CM&S is also a very promising technology into the broader narrative of advancing regulatory science and healthcare innovation.
- The book underscores the necessity for guidelines akin to the GxP standards, yet specifically tailored for in silico methodologies.
- It leverages the ASMEV&V40 – 2018 standard as a model, proposing a consensus-driven framework to support CM&S with good practices applicable across the spectrum of medical solutions.
- This partnership illustrates the proactive engagement between regulatory agencies and the scientific community to foster advancements in medical product development.